1.	STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot) Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: STARS-Pilot (05/55 Graham), NCT00126360
2.	Aromatase Inhibitor Clinical Trial Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 40 to 70 Sponsor: NIGMS Protocol IDs: 0412-14, UO1-GM61373-06, NCT00228956
3.	The MONET - Study: MR Mammography of Nonpalpable Breast Tumors Phase: Phase IV Type: Diagnostic Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: UMC Utrecht, NCT00302120
4.	Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma Phase: Phase IV Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: seromprotocol, NCT00307606
5.	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EGF103659, NCT00338247
6.	National Screening in Denmark With MR Versus Mammography and Ultrasound of Women With BRCA1 or BRCA2 Mutations Phase: Phase IV Type: Screening Status: Active Age: 25 to 70 Sponsor: Other Protocol IDs: DBCG07MRBRCA, NCT00413491
7.	Doxorubicin Hydrochloride Liposome or Capecitabine as First-Line Chemotherapy in Treating Women With Metastatic Breast Cancer Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: SPRI-P04445, EU-20654, NCT00266799, SPRI-PELICAN
8.	A Study of Liposomal Doxorubicin in Women With Breast Cancer Exploiting Tissue Doppler Imaging Phase: Phase IV Type: Diagnostic, Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: LITE Randomized Pilot Study, NCT00531973
9.	Yunzhi as Dietary Supplement in Breast Cancer Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: YUNZHI-BC, NCT00647075
10.	Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients Phase: Phase IV Type: Supportive care Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: GLU_07, NCT00772824
11.	An Observational Study Of Pregnancy And Pregnancy Outcomes In Women With Breast Cancer Treated With Herceptin Or Perjeta In Combination With Herceptin During Pregnancy Or Within 6 Months Prior To Conception (MotHER) Phase: Phase IV Type: Natural history/Epidemiology Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: H4621g, NCT00833963
12.	Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-Risk" Breast Cancer Patients Phase: Phase IV Type: Treatment Status: Active Age: 50 and over Sponsor: Other Protocol IDs: S07-002, 1098558, NCT00882596
13.	A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6 Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: GCO# 08-1373, NCT00900744
14.	Lymphedema Following Hand/Wrist Surgery in Women Post Axillary Node Dissection Phase: Phase IV Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-09-14B, NCT00984269
15.	Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer Phase: Phase IV Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 30 to 65 Sponsor: Other Protocol IDs: 88-04-27-9683, NCT01049295
16.	Clinical Outcomes After Letrozole Treatment According to the Estrogen Receptor Expression in Postmenopausal Women Phase: Phase IV Type: Treatment Status: Active Age: Postmenopausal Sponsor: Other Protocol IDs: KBCSG006, NCT01069211
17.	Reducing Pain and Disability After Breast Cancer Surgery Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2006711-01, to be entered, NCT01089933
18.	A Study of Avastin With Taxane Therapy in Patients With Triple Negative Breast Cancer Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: ML22780, 2009-014279-37, NCT01094184
19.	Pharmacology of Adjuvant Hormonotherapy in Breast Cancer Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 09 SEIN 09, NCT01127295
20.	A Clinical Trial About the Contribution of Manual Lymph Drainage in Complex Physical Therapy for Patients With Lymphoedema Secondary to Mastectomy Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: TFCDLM-07, NCT01152099
21.	Interpersonal Therapy for Depression in Breast Cancer Phase: Phase IV Type: Behavioral study, Supportive care Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: #5996, NCT01191580
22.	Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast Cancer Phase: Phase IV Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: BCP06, NCT01199432
23.	Clinical Trial Comparing Outcomes of Breast Conserving Operations With Classic v High-frequency Electrocoagulation Phase: Phase IV Type: Supportive care, Treatment Status: Active Age: 18 to 100 Sponsor: Other Protocol IDs: NKEBN/219/2010, NCT01216254
24.	Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CRAD001JIL05, NCT01231659
25.	Intervention Study of Depression in Breast Cancer Patients Phase: Phase IV Type: Supportive care Status: Approved-not yet active Age: 20 to 65 Sponsor: Other Protocol IDs: 2009BAI77B06-3, NCT01256008